Direct Rx recalls Ropinirole, USP, 0.25 mg Tablets, Rx Only, Packaged as a 30-count bottle, NDC 72189-0364-30; Packaged and Distributed By
Recalled April 5, 2023 · FDA recall D-0478-2023 · Direct Rx
Hazard
cGMP deviations · FDA Class II
Units
9 bottles
Sold at
Nationwide in the USA
Description
cGMP deviations
Product
Ropinirole, USP, 0.25 mg Tablets, Rx Only, Packaged as a 30-count bottle, NDC 72189-0364-30; Packaged and Distributed By: Direct Rx, Dawsonville, GA 30534
Manufacturer(s)
Direct Rx
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →